379 related articles for article (PubMed ID: 12501562)
1. [Polymyositis/scleroderma autoantibody-positive scleroderma with dermatomyositis (scleromyositis)].
Török L; Dankó K; Cserni G; Szücs G
Orv Hetil; 2002 Nov; 143(45):2553-6. PubMed ID: 12501562
[TBL] [Abstract][Full Text] [Related]
2. PM-SCL autoantibody positive scleroderma with polymyositis (mechanic's hand: clinical aid in the diagnosis).
Török L; Dankó K; Cserni G; Szûcs G
J Eur Acad Dermatol Venereol; 2004 May; 18(3):356-9. PubMed ID: 15096156
[TBL] [Abstract][Full Text] [Related]
3. Anti-signal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathy.
Kao AH; Lacomis D; Lucas M; Fertig N; Oddis CV
Arthritis Rheum; 2004 Jan; 50(1):209-15. PubMed ID: 14730618
[TBL] [Abstract][Full Text] [Related]
4. Childhood sclerodermatomyositis: report of a case with the anti-PM/Scl antibody and mechanic's hands.
García-Patos V; Bartralot R; Fonollosa V; Arnal C; Boronat M; Gelpí C; Rodríguez JL; Castells A
Br J Dermatol; 1996 Oct; 135(4):613-6. PubMed ID: 8915158
[TBL] [Abstract][Full Text] [Related]
5. C1D is a major autoantibody target in patients with the polymyositis-scleroderma overlap syndrome.
Schilders G; Egberts WV; Raijmakers R; Pruijn GJ
Arthritis Rheum; 2007 Jul; 56(7):2449-54. PubMed ID: 17599775
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies in scleroderma and polymyositis: an update.
McCarty GA
Semin Dermatol; 1991 Sep; 10(3):206-16. PubMed ID: 1931570
[TBL] [Abstract][Full Text] [Related]
7. Scleromyositis (scleroderma/polimyositis overlap) is an entity.
Jablonska S; Blaszyk M
J Eur Acad Dermatol Venereol; 2004 May; 18(3):265-6. PubMed ID: 15096133
[No Abstract] [Full Text] [Related]
8. [Interstitial lung manifestations in systemic scleroderma. Correlation between alveolitis, autoantibodies and clinical manifestations].
Witt C; Hiepe F; Brenke A; Romberg B; Apostoloff E
Z Arztl Fortbild (Jena); 1994 Nov; 88(11):867-71. PubMed ID: 7839707
[No Abstract] [Full Text] [Related]
9. The assessment of anti-endothelial cell antibodies in scleroderma-associated pulmonary fibrosis. A study of indirect immunofluorescent and western blot analysis in 49 patients with scleroderma.
Wusirika R; Ferri C; Marin M; Knight DA; Waldman WJ; Ross P; Magro CM
Am J Clin Pathol; 2003 Oct; 120(4):596-606. PubMed ID: 14560571
[TBL] [Abstract][Full Text] [Related]
10. Anti-lipoprotein lipase antibody in systemic sclerosis: association with elevated serum triglyceride concentrations.
Kodera M; Hayakawa I; Komura K; Yanaba K; Hasegawa M; Takehara K; Sato S
J Rheumatol; 2005 Apr; 32(4):629-36. PubMed ID: 15801017
[TBL] [Abstract][Full Text] [Related]
11. Childhood scleromyositis: an overlap syndrome associated with PM-Scl antibody.
Błaszczyk M; Jabłońska S; Szymańska-Jagiełło W; Jarzabek-Chorzelska M; Chorzelski T; Mohamed AH
Pediatr Dermatol; 1991 Mar; 8(1):1-8. PubMed ID: 1907368
[TBL] [Abstract][Full Text] [Related]
12. Identification of a novel autoantibody reactive with 155 and 140 kDa nuclear proteins in patients with dermatomyositis: an association with malignancy.
Kaji K; Fujimoto M; Hasegawa M; Kondo M; Saito Y; Komura K; Matsushita T; Orito H; Hamaguchi Y; Yanaba K; Itoh M; Asano Y; Seishima M; Ogawa F; Sato S; Takehara K
Rheumatology (Oxford); 2007 Jan; 46(1):25-8. PubMed ID: 16728436
[TBL] [Abstract][Full Text] [Related]
13. [Progressive scleroderma and dermatomyositis].
Ricken D
Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():751-6. PubMed ID: 77111
[No Abstract] [Full Text] [Related]
14. A histopathologic study of mechanic's hands associated with dermatomyositis: a report of five cases.
Mii S; Kobayashi R; Nakano T; Harada H; Okada M; Matsui Y; Fujii T; Eto H
Int J Dermatol; 2009 Nov; 48(11):1177-82. PubMed ID: 20064170
[TBL] [Abstract][Full Text] [Related]
15. "Centripetal flagellate erythema": a cutaneous manifestation associated with dermatomyositis.
Nousari HC; Ha VT; Laman SD; Provost TT; Tausk FA
J Rheumatol; 1999 Mar; 26(3):692-5. PubMed ID: 10090184
[TBL] [Abstract][Full Text] [Related]
16. HLA class II haplotype and autoantibody associations in children with juvenile dermatomyositis and juvenile dermatomyositis-scleroderma overlap.
Wedderburn LR; McHugh NJ; Chinoy H; Cooper RG; Salway F; Ollier WE; McCann LJ; Varsani H; Dunphy J; North J; Davidson JE;
Rheumatology (Oxford); 2007 Dec; 46(12):1786-91. PubMed ID: 18003662
[TBL] [Abstract][Full Text] [Related]
17. [Overlap syndrome].
Kasukawa R; Kanno T; Takeda I
Ryoikibetsu Shokogun Shirizu; 2000; (31):427-9. PubMed ID: 11269125
[No Abstract] [Full Text] [Related]
18. Clinical and serological heterogeneity in patients with anticentromere antibodies.
Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y
J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324
[TBL] [Abstract][Full Text] [Related]
19. [Immunologic tests: Anti-polymyositis-scleroderma (PM-Scl) antibody].
Takasaki Y
Nihon Rinsho; 2005 Jul; 63 Suppl 7():502-4. PubMed ID: 16111314
[No Abstract] [Full Text] [Related]
20. Skin lesions in anti-Pm-Scl-70 positive systemic sclerosis-dermatomyositis overlap syndrome improve during local PUVA phototherapy.
Mohanna M; Distler O; Sprott H; Kündig T; French LE; Hofbauer G
Eur J Dermatol; 2013; 23(5):730-1. PubMed ID: 24126033
[No Abstract] [Full Text] [Related]
[Next] [New Search]
